Generic Metaglip

Generic Metaglip is sold under the name Glipizide and Metformin tablets, and is available in three different strengths: 2.5 mg/250 mg, 2.5 mg/500 mg, and 5 mg/500 mg. The FDA has assigned an "AB" rating to the drug, meaning that it is equivalent to the brand-name medication. However, generic Metaglip may contain other ingredients, such as fillers and dyes, which may cause problems for people with allergies.

Generic Metaglip: An Overview

Metaglip® (glipizide and metformin) is a prescription medication that has been licensed to treat type 2 diabetes. It is a combination medication containing glipizide (Glucotrol® or Glucotrol XL®) and metformin hydrochloride (Fortamet®, Glucophage®, Glucophage XR®, Glumetza®, or Riomet®).
 
Metaglip was first manufactured by Bristol-Myers Squibb Company. The patent for the drug has since expired, which means a generic Metaglip can now be produced.
 

Strengths of Generic Metaglip

Generic Metaglip is available in the following strengths:
 
  • Glipizide and Metformin 2.5 mg/250 mg tablets -- containing 2.5 mg glipizide and 250 mg metformin
  • Glipizide and Metformin 2.5 mg/500 mg tablets -- containing 2.5 mg glipizide and 500 mg metformin
  • Glipizide and Metformin 5 mg/500 mg tablets -- containing 5 mg glipizide and 500 mg metformin.
     

Who Makes Generic Metaglip?

Generic Metaglip is currently made by two companies: Teva Pharmaceuticals and Corepharma.
 
 

Add
Email
Print
(Generic Metaglip Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation
Referring Pages Articles